| Literature DB >> 35197771 |
Amal Dbeibia1, Fadia Ben Taheur1, Khadijah A Altammar2, Najla Haddaji3, Abdelkarim Mahdhi1, Zahra Amri4, Ridha Mzoughi1, Chédia Jabeur1,5.
Abstract
In the current study the potential use of aqueous and methanolic extracts of Ephedra alata aerial parts as biological control agent against pathogenic bacteria and especially Staphylococcus aureus methicillin resistant isolated from auricular infections was evaluated. Chemical tests and spectrophotometric methods were used for screening and quantification of phytochemicals. The assessment of the antioxidant activity was accomplished by DPPH and ABTS radicals scavenging assays. Extracts were evaluated for their antibacterial efficacy by diffusion and microdilution methods. Biofilm inhibition was tested using XTT assay and the cytotoxicity of extracts was carried out on Vero cell line. The GC-FID analysis revealed that E. alata was rich in unsatured fatty acids. In addition, the aqueous extract had the highest flavonoid and protein contents (30.82 mg QE /g dry extract and 98.92 mg BSAE/g dry extract respectively). However, the methanolic extract had the highest phenolic, sugars and tannins. The antioxidant activity demonstrated that the aqueous extract exhibited the strong potency (IC50 ranged between 0.001 and 0.002 mg/mL). Both extracts displayed antimicrobial activity on Gram negative and positive strains. They were effective against S. aureus isolated from auricular infections. The tested extracts were able to inhibit biofilm formation with concentration-dependent manner. Moreover, no cytotoxic effect on Vero cells line was demonstrated for the extracts. Overall, our findings highlight the potential use of E. alata extract as a novel source of bioactive molecules with antioxidant, antibacterial and antiobiofilm effects for the control of infectious disease especially those associated to S. aureus methicillin resistant.Entities:
Keywords: Antibacterial potency; Antibiofilm activity; Antioxidant effect; Cytotoxicity; Ephedra alata; Fatty acids; Mineral composition
Year: 2021 PMID: 35197771 PMCID: PMC8848002 DOI: 10.1016/j.sjbs.2021.09.071
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.219
Fig. 1Map of the different location sites of Ephedra alata in Tunisia.
Proximate and mineral composition of Ephedra alata aerial parts.
| Proximate composition | Mineral composition | ||||||
|---|---|---|---|---|---|---|---|
| Plant | Moisture | Ash | Phosphorus (P) | Calcium (Ca) | Iron (Fe) | Sodium (Na) | Potassium (k) |
| 7.76 ± 0.05 | 8.28 ± 0.00 | 160 ± 0.00 | 1540 ± 0.03 | 6 ± 0.00 | 20 ± 0.30 | 1380 ± 0.00 | |
Values presented are means ± SD of triplicate measurements. DW: dry weight.
Fatty acids analysis of Ephedra alata aerial parts.
| Lauric acid | C12:0 | 0.54 |
| Myristic acid | C14:0 | 0.63 |
| Myristoleic acid | C14:1 | 0.78 |
| Palmitic acid | C16:0 | 18.91 |
| Palmitoleic acid | C16:1 | 0.77 |
| Margaric acid | C17:0 | 0.54 |
| Heptadecenoic acid | C17:1 | 0.26 |
| Stearic acid | C18:0 | 2.28 |
| Oleic acid | C18:1 cis 9 | 17.43 |
| Vaccenic acid | C18:1 cis 11 | 1.33 |
| Trans-9, | C18:2 (cis 9, cis12) | 23.08 |
| α-Linolenic acid | C18:3 w3 | 3.56 |
| γ-Linolenic acid | C18:3 w6 | 23.69 |
| Arachidic acid | C20:0 | 0.48 |
| Eicosenoic acid | C20:1 | 0.86 |
| Eicosadienoic acid | C20:2 | 0.17 |
| Eicosatrienoic acid | C20:3 w3 | 1.55 |
| Dihomo-γ-linolenic acid | C20:3 w6 | 0.75 |
| Heneicosylic acid | C21:0 | 0.57 |
| Behenic acid | C22:0 | 0.20 |
| Erucic acid | C22:1 w9 | 0.47 |
| Docosadienoic acid | C22:2 | 0.35 |
| Docosatrienoic acid | C22:3 | 0.05 |
| Docosatetraenoic acid | C22:4 | 0.09 |
| Docosapentaenoic acid | C22:5 | 0.24 |
| Lignoceric acid | C24:0 | 0.33 |
| Nervonic acid | C24:1 | 0.07 |
| Total satured fatty acids | 24.48 | |
| Total polyunsatured fatty acids | 21.97 | |
| Total monounsatured fatty acids | 53.53 |
Phytochemical screening of E. alata aerial parts extracts.
+++: relatively high in abundance; ++: relatively moderate in abundance; +: relatively low presence; -: not detected.
Total bioactive components of E. alata aerial parts extracts.
| Extracts | Extracts Yields (%) | Total flavonoids (mg QE /g dry extract) | Total phenols (mg GAE/g dry extract) | Total sugars (mg GE /g dry extract) | Total tannins (mg TAE/g dry extract) | Total proteins (mg BSAE/g dry extract) |
|---|---|---|---|---|---|---|
| Aqueous | 38.2 ± 0.2 | 30.82 ± 0.49 | 124.11 ± 1.18 | 0.08 ± 0.02 | 5.54 ± 0.29 | 98.62 ± 2.29 |
| Methanolic | 5.23 ± 0.0 | 27.89 ± 0.44 | 125.73 ± 1.68 | 2.02 ± 0.07 | 5.55 ± 0.09 | 97.12 ± 0.19 |
Values presented are means ± SD of triplicate measurements. GAE: Gallic Acid Equivalent; QE: Quercetin Equivalent; GE: Glucose Equivalent; TAE: Tannic Acid Equivalent; BSA: Bovine Serum Albumin Equivalent.
Antioxidant activities of E. alata extracts.
| IC50 (mg/mL) | ||
|---|---|---|
| Extracts | DPPH | ABTS |
| Methanolic | 0.557 ± 0.028c | 0.143 ± 0.014c |
| Aqueous | 0.001 ± 0.0001a | 0.002 ± 0.0001a |
| Ascorbic acid | 0.014 ± 0.0001b | 0.015 ± 0.002b |
Values presented are means ± SD of triplicate measurements.
The letters (a–c) indicate a significant difference in the same line between the different antioxidant methods according to the Duncan test (p < 0.05).
IC50: The concentration of extracts at which 50% of antioxidant activity were shown.
Antibacterial activities of the Ephedra alata extracts.
| Bacteria organisms | Aqueous extract | Methanolic extract | ||||
|---|---|---|---|---|---|---|
| DIZ ± SD | MIC (mg/mL) | MBC (mg/mL) | DIZ ± SD | MIC (mg/mL) | MBC (mg/mL) | |
| 12 ± 0 | 12.5 | >25 | 16 ± 0.33 | 6.25 | >25 | |
| 11 ± 0 | 12.5 | 12.5 | 12 ± 0.33 | 1.56 | 6.25 | |
| Sa12 | 8 ± 0 | 6.25 | >25 | 13 ± 0.33 | 3.125 | 12.5 |
| Sa16 | 11 ± 0 | 3.12 | 25 | 11 ± 0 | 0.09 | 12.5 |
| Sa26 | 10 ± 1.4 | 12.5 | >25 | 11.5 ± 0.7 | 3.12 | >25 |
| Sa27 | 9 ± 0 | 25 | >25 | 11 ± 0 | 3.12 | 12.5 |
| Sa32 | 10 ± 0 | 12.5 | >25 | 13.5 ± 0.7 | 0.02 | >25 |
DIZ: diameter inhibition zone; SD: standard deviation; MIC: minimum inhibitory concentration; MBC: minimum bactericidal concentration.
Antibiofilm activity of Ephedra alata extracts against references and oral strains.
| BI50 (mg/mL) | ||
|---|---|---|
| Aqueous extract | Methanolic extract | |
| 6.78 | 6.74 | |
| 5.96 | 4.55 | |
| >25 | >25 | |
| 12.25 | 13.96 | |
| 17.13 | 17.67 | |
| >25 | >25 | |
BI50: minimum biofilm inhibition concentration of E. alata extracts able to inhibit 50% on the biofilm formation.
Fig. 2Cytotoxic activity (expressed as % of viability) of VERO cell line after 24 h of incubation with aqueous (A) or methanolic (B) extracts obtained from aerial parts of E. alata. White bars represent control. Values are presented as mean ± SD of triplicate measurements.